COMBINATIONS OF A LIPOSOMAL WATER-SOLUBLE CAMPTOTHECIN WITH CETUXIMAB OR BEVACIZUMAB
摘要
Compositions which comprise a liposomal water-soluble camptothecin and optionally a liposomal fluoropyrimidine in combination with a vascular epithelial growth factor (VEGF) inhibitor such as cetuximab or an epidermal growth factor receptor (EGFR) inhibitor such as bevacizumab are useful in achieving enhanced therapeutic effects for the treatment of cancer.
申请公布号
WO2010043050(A1)
申请公布日期
2010.04.22
申请号
WO2009CA01483
申请日期
2009.10.16
申请人
CELATOR PHARMACEUTICALS CORPORATION;TARDI, PAUL;MAYER, LAWRENCE;BERMUDES, DAVID
